Patrick Forde, Professor at the Johns Hopkins University, posted the following on LinkedIn:
“In the presidential session at the World Conference on Lung Cancer today, WCLC2024, I presented data to help guide use of adjuvant immunotherapy after neoadjuvant chemo-immunotherapy for lung cancer. This is a key clinical question in management of lung cancer, and these data may help guide management in near future.”
Source: Patrick Forde/LinkedIn
